Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Endocr Res ; 35(1): 1-16, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20136514

RESUMO

Pomegranate (Punica granatum) seed linolenic acid isomers were evaluated as selective estrogen receptor modulators (SERMs) in vitro. Punicic acid (PA) inhibited (IC(50)) estrogen receptor (ER) alpha at 7.2 microM, ERbeta at 8.8 microM; alpha-eleostearic acid (AEA) inhibited ERalpha/ERbeta at 6.5/7.8 microM. PA (not AEA) agonized ERalpha/ERbeta (EC(50)) at 1.8/2 microM, antagonizing at 101/80 microM. AEA antagonized ERalpha/ERbeta at 150/140 microM. PA and AEA induced ERalpha and ERbeta mRNA expression in MCF-7, but not in MDA-MB-231. Overall, the results show PA and AEA are SERMs.


Assuntos
Ácidos Linoleicos/farmacologia , Lythraceae/química , Fitoestrógenos/farmacologia , Receptores de Estrogênio/efeitos dos fármacos , Receptores de Estrogênio/fisiologia , Sementes/química , Neoplasias da Mama , Divisão Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Relação Dose-Resposta a Droga , Receptor alfa de Estrogênio/genética , Receptor alfa de Estrogênio/metabolismo , Receptor beta de Estrogênio/genética , Receptor beta de Estrogênio/metabolismo , Ácidos Graxos/análise , Humanos , Isomerismo , Ácidos Linoleicos/química , Ácidos Linoleicos/metabolismo , Ácidos Linoleicos Conjugados/metabolismo , Ácidos Linolênicos/metabolismo , Fitoestrógenos/metabolismo , Óleos de Plantas/química , RNA Mensageiro/análise , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Moduladores Seletivos de Receptor Estrogênico/metabolismo , Moduladores Seletivos de Receptor Estrogênico/farmacologia
2.
J Microbiol Biotechnol ; 19(12): 1536-41, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20075615

RESUMO

The DNA shuffling technique has been used to generate libraries of evolved enzymes in thermostability. We have shuffled two thermostable cytidine deaminases (CDAs) from Bacillus caldolyticus DSM405 (T53) and B. stearothermophilus IFO12550 (T101). The shuffled CDA library (SH1067 and SH1077 from the first round and SH2426 and SH2429 from the second round) showed various patterns in thermostability. The CDAs of SH1067 and SH1077 were more thermostable than that of T53. SH2426 showed 150% increased half-time than that of T53 at 70 degrees C. The CDA of SH2429 showed about 200% decreased thermostability than that of T53 at 70 degrees C. A single amino acid residue replacement that presented between SH1077 and SH2429 contributed to dramatic changes in specific activity and thermostability. On SDS-PAGE, the purified CDA of SH1077 tetramerized, whereas that of SH2429 denatured and became almost monomeric at 80 degrees C. A simulated three-dimensional structure for the mutant CDA was used to interpret the mutational effect.


Assuntos
Citidina Desaminase/química , Citidina Desaminase/genética , Temperatura Alta , Bacillus/enzimologia , Bacillus/genética , Citidina Desaminase/metabolismo , Embaralhamento de DNA , DNA Bacteriano/genética , DNA Bacteriano/metabolismo , Evolução Molecular Direcionada , Estabilidade Enzimática , Genes Bacterianos , Microbiologia Industrial , Modelos Moleculares , Estrutura Quaternária de Proteína , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/química , Análise de Sequência de Proteína
3.
Toxicol Appl Pharmacol ; 231(3): 401-12, 2008 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-18603276

RESUMO

A pharmacological dose (2.5-10 microM) of 17alpha-estradiol (17alpha-E(2)) exerted a cytotoxic effect on human leukemias Jurkat T and U937 cells, which was not suppressed by the estrogen receptor (ER) antagonist ICI 182,780. Along with cytotoxicity in Jurkat T cells, several apoptotic events including mitochondrial cytochrome c release, activation of caspase-9, -3, and -8, PARP degradation, and DNA fragmentation were induced. The cytotoxicity of 17alpha-E(2) was not blocked by the anti-Fas neutralizing antibody ZB-4. While undergoing apoptosis, there was a remarkable accumulation of G(2)/M cells with the upregulatoin of cdc2 kinase activity, which was reflected in the Thr56 phosphorylation of Bcl-2. Dephosphorylation at Tyr15 and phosphorylation at Thr161 of cdc2, and significant increase in the cyclin B1 level were underlying factors for the cdc2 kinase activation. Whereas the 17alpha-E(2)-induced apoptosis was completely abrogated by overexpression of Bcl-2 or by pretreatment with the pan-caspase inhibitor z-VAD-fmk, the accumulation of G(2)/M cells significantly increased. The caspase-8 inhibitor z-IETD-fmk failed to influence 17alpha-E(2)-mediated caspase-9 activation, but it markedly reduced caspase-3 activation and PARP degradation with the suppression of apoptosis, indicating the contribution of caspase-8; not as an upstream event of the mitochondrial cytochrome c release, but to caspase-3 activation. In the presence of hydroxyurea, which blocked the cell cycle progression at the G(1)/S boundary, 17alpha-E(2) failed to induce the G(2)/M arrest as well as apoptosis. These results demonstrate that the cytotoxicity of 17alpha-E(2) toward Jurkat T cells is attributable to apoptosis mainly induced in G(2)/M-arrested cells, in an ER-independent manner, via a mitochondria-dependent caspase pathway regulated by Bcl-2.


Assuntos
Apoptose/fisiologia , Divisão Celular/fisiologia , Estradiol/toxicidade , Fase G2/fisiologia , Leucemia-Linfoma de Células T do Adulto/metabolismo , Apoptose/efeitos dos fármacos , Caspases/genética , Caspases/metabolismo , Morte Celular/efeitos dos fármacos , Morte Celular/fisiologia , Divisão Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Estradiol/uso terapêutico , Fase G2/efeitos dos fármacos , Humanos , Células Jurkat , Leucemia-Linfoma de Células T do Adulto/tratamento farmacológico , Leucemia-Linfoma de Células T do Adulto/genética , Células U937
4.
J Microbiol Biotechnol ; 18(12): 1869-73, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19131686

RESUMO

An isolate from holothurians was identified as an eicosapentaenoic acid (EPA)-producing bacterium KMG427, which is characterized by EPA synthesis efficiency, by thin layer and gas chromatographic analyses. The EPA production was maximized to more than 10% of the total fatty acids by incubation at 4o degrees C after cell proliferation at 20 degrees C. The isolated bacterium was categorized as Gramnegative, rod-shaped, aerobic, and motile with a single polar flagellum. According to phylogenetic analysis based on morphological and physiological specificities as an EPA-producing bacterium, the isolate KMG427 was found to belong to the genus Shewanella. The 16S rDNA of KMG427 was revealed to have 100% of sequence identity to that of S. hanedai CIP 103207T. Therefore, the isolate might be classified and identified as Shewanella sp. KMG427.


Assuntos
Ácido Eicosapentaenoico/metabolismo , Shewanella/classificação , Cromatografia Gasosa , DNA Ribossômico/genética , Ácidos Graxos/biossíntese , Genes Bacterianos , Lipídeos de Membrana/metabolismo , Fenótipo , Filogenia , RNA Ribossômico 16S/genética , Shewanella/genética , Shewanella/metabolismo , Temperatura
5.
Life Sci ; 71(18): 2145-52, 2002 Sep 20.
Artigo em Inglês | MEDLINE | ID: mdl-12204772

RESUMO

Resveratrol is a phytoalexin found in grapes and other foods that has been shown to have anticancer and anti-inflammatory effects. Because protein kinase CKII is involved in cell proliferation and oncogenesis, we examined whether resveratrol could modulate CKII activity. Resveratrol was shown to inhibit the phosphotransferase activity of CKII with IC(50) of about 10 microM. Steady state studies revealed that resveratrol acted as a competitive inhibitor with respect to the substrate ATP. A value of 1.2 microM was obtained for the apparent K(i). Resveratrol also inhibited the catalytic reaction of CKII with GTP as substrate. Furthermore, resveratrol inhibits endogenous CKII activity on protein substrates in HeLa cell lysates. These results suggest that resveratrol is likely to function by inhibiting oncogenic disease, at least in part, through the inhibition of CKII activity.


Assuntos
Anticarcinógenos/farmacologia , Inibidores Enzimáticos/farmacologia , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Estilbenos/farmacologia , Vitis/química , Vinho/análise , Trifosfato de Adenosina/metabolismo , Caseína Quinase II , Catálise , Células HeLa , Humanos , Indicadores e Reagentes , Cinética , Fosforilação , Resveratrol
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA